Celgene Corp (CELG)

CELG (NASDAQ:Drugs) EQUITY
$129.43
neg -1.80
-1.40%
Today's Range: 128.61 - 131.17 | CELG Avg Daily Volume: 3,977,400
Last Update: 08/17/17 - 11:27 AM EDT
Volume: 1,415,473
YTD Performance: 13.40%
Open: $130.57
Previous Close: $131.26
52 Week Range: $92.98 - $137.54
Oustanding Shares: 782,350,672
Market Cap: 102,777,407,781
6-Month Chart
TheStreet Ratings Grade for CELG
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 16 13 14 13
Moderate Buy 0 0 0 0
Hold 2 3 2 3
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.22 1.38 1.25 1.38
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 40.80
Price Earnings Comparisons:
CELG Sector Avg. S&P 500
40.80 40.80 36.10
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
9.97% 17.02% 46.49%
GROWTH 12 Mo 3 Yr CAGR
Revenue 21.30 0.70 0.20
Net Income 24.80 0.40 0.11
EPS 28.40 0.50 0.14
Earnings for CELG:
EBITDA 3.71B
Revenue 11.23B
Average Earnings Estimates
Qtr (09/17) Qtr (12/17) FY (12/17) FY (12/18)
Average Estimate $1.72 $1.78 $6.68 $8.41
Number of Analysts 8 8 8 4
High Estimate $1.84 $1.84 $6.81 $8.74
Low Estimate $1.68 $1.72 $6.61 $8.23
Prior Year $1.39 $1.41 $5.18 $6.68
Growth Rate (Year over Year) 23.92% 26.06% 28.86% 25.99%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
The market seems fully valued, so I'm building up cash as we head into historically volatile months.
Stop losses do not work in this part of the market.

Back to Basics in Biotech Real Money Pro($)

Stop losses do not work in this part of the market.
CELG looks like it has a promising future, according to the charts.
The word of the day is "rotation." No "thanks a latte" for me -- I'm staying with my core short of Starbucks (SBUX) . But buy Hartford Insurance Group (HIG
Multiples have become quite rich and dysfunction in Washington could end up biting the markets.

Biotech Bucking the Trend Real Money Pro($)

Coming up on the two-hour mark on trading. The market is down slightly down across the board, with Nasdaq being affected by disappointing results from Starbucks (SBUX) and Amazon (AMZN) . The failure to even getting a "skinny" repeal and replacement of the Affordable Care Act through the Senate is casting doubts about the other key parts of the Administration's agenda. These include tax reform and a boost in infrastructure spending. These have been key factors to the market's rally since the November election. Border adjustment tax has been dropped to try to get more unity from the party, but chances of anything significant passing on the tax front seem to be dimming. Chances of some sort of correction seem to be growing.
It is good to be sitting in for Doug Kass here on the Daily Diary as we look to end the trading week on a positive note. It is also good to see the Yankees start to win close games again after losing so many of them in the weeks leading into the All-Star break. The trade they made with the White Sox to bolster their bullpen already is paying dividends.

Here's What Up (and Down) Real Money Pro($)

After 90 minutes of trading here are some market features:   * Bonds are getting schmeissed. The 10-year U.S. note yield is close to…
Case in point: Home Depot and Lowe's.

Columnist Conversations

we like this chart here, it appears ready to move higher. BOUGHT BZUN OCT 35 CALL AT 3.40
Large-cap, high-quality McKesson (MCK) is too cheap now, at $147.51 or so. The stock hit $243.60 more than 2.5...
View Chart »  View in New Window » View Chart » 

REAL MONEY'S BEST IDEAS

News Breaks

Powered by

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.